Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Liposomal doxorubicin

P G Tardi1, N L Boman, P R Cullis

  • 1Inex Pharmaceuticals Corporation, Vancouver, British Columbia, Canada.

Journal of Drug Targeting
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The 60-year evolution of lipid nanoparticles for nucleic acid delivery.

Nature reviews. Drug discovery·2024
Same author

Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2022
Same author

Structural Properties of Inverted Hexagonal Phase: A Hybrid Computational and Experimental Approach.

Langmuir : the ACS journal of surfaces and colloids·2020
Same author

Coating of PLA-nanoparticles with cyclic, arginine-rich cell penetrating peptides enables oral delivery of liraglutide.

Nanomedicine : nanotechnology, biology, and medicine·2019
Same author

Ionizable amino lipid interactions with POPC: implications for lipid nanoparticle function.

Nanoscale·2019
Same author

Lipid nanoparticle delivery systems for siRNA-based therapeutics.

Drug delivery and translational research·2015
Same journal

Tubulin as a Well-Established Yet Underexploited Target: New Opportunities for Drugs Repurposing?

Journal of drug targeting·2026
Same journal

Physcion-loaded, folic acid-conjugated DSPE-PEG liposomes for targeted therapy of ulcerative colitis.

Journal of drug targeting·2026
Same journal

Enzyme-responsive 2-dimensional nanomaterials for targeted breast cancer treatment.

Journal of drug targeting·2026
Same journal

Integrating antibody-drug conjugates, multispecific antibodies, targeted protein degradation and nanomedicine in precision oncology.

Journal of drug targeting·2026
Same journal

Nanomaterials for subcellular organelle targeting: unlocking new avenues for enhanced therapeutic effectiveness.

Journal of drug targeting·2026
Same journal

Eletriptan HBr-loaded solid lipid nanoparticle-integrated microneedles: a targeted and minimally invasive approach for migraine management.

Journal of drug targeting·2026
See all related articles

Optimizing liposome size and drug retention improves liposomal doxorubicin's efficacy and reduces toxicity. These physical characteristics are key to enhancing therapeutic benefits for cancer treatment.

Area of Science:

  • Oncology
  • Pharmaceutics
  • Nanomedicine

Background:

  • Doxorubicin is a widely used chemotherapy drug for various cancers.
  • Liposomal encapsulation alters doxorubicin's pharmacokinetic and biodistribution profiles.
  • Liposome physical properties critically influence drug retention and therapeutic outcomes.

Purpose of the Study:

  • To review the impact of liposome physical characteristics on liposomal doxorubicin toxicity and efficacy.
  • To explore how varying liposome size, lipid composition, and drug-to-lipid ratio affects therapeutic activity.
  • To understand the relationship between formulation parameters and clinical performance.

Main Methods:

  • Review of studies investigating liposomal doxorubicin formulations with diverse physical properties.

Related Experiment Videos

  • Analysis of data correlating liposome size, lipid composition, and drug-to-lipid ratio with toxicity and efficacy.
  • Utilizing the transmembrane pH gradient-dependent drug encapsulation procedure to independently vary physical properties.

    • Main Results:

    • Formulation toxicity is directly related to drug retention within the circulation.
    • Antitumor efficacy demonstrates higher sensitivity to liposome size compared to other parameters.
    • Independent variation of physical properties allows for targeted optimization.

    Conclusions:

    • Liposome physical characteristics, including size and drug retention, are critical determinants of liposomal doxorubicin's therapeutic index.
    • Optimizing these parameters can lead to enhanced efficacy and reduced toxicity.
    • Tailoring liposomal doxorubicin formulations holds significant potential for improved cancer therapy.